硫酰胺类药物治疗甲亢患者时甲状腺刺激物与3,5,3'-三碘甲状腺原氨酸抑制性之间的相关性：基于甲状腺刺激活性和促甲状腺激素替代活性检测方法的比较 - Suppr

Suppr

超能文献

Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.

作者信息

Kuzuya N, Chiu S C, Ikeda H, Uchimura H, Ito K, Nagataki S

出版信息

J Clin Endocrinol Metab. 1979 Apr;48(4):706-11. doi: 10.1210/jcem-48-4-706.

DOI:10.1210/jcem-48-4-706

PMID:581876

Abstract

摘要

相似文献

Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.硫酰胺类药物治疗甲亢患者时甲状腺刺激物与3,5,3'-三碘甲状腺原氨酸抑制性之间的相关性：基于甲状腺刺激活性和促甲状腺激素替代活性检测方法的比较

J Clin Endocrinol Metab. 1979 Apr;48(4):706-11. doi: 10.1210/jcem-48-4-706.

Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.甲状腺功能亢进治疗期间血清长效甲状腺刺激素含量与甲状腺抑制性的分离

J Clin Endocrinol Metab. 1970 Apr;30(4):524-8. doi: 10.1210/jcem-30-4-524.

J Clin Endocrinol Metab. 1984 Jan;58(1):62-9. doi: 10.1210/jcem-58-1-62.

Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.长效甲状腺刺激素与格雷夫斯病患者血清三碘甲状腺原氨酸、甲状腺素及促甲状腺激素水平的相关性

J Assoc Physicians India. 1975 Feb;23(2):111-4.

Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood.

J Pediatr. 1992 Aug;121(2):206-9. doi: 10.1016/s0022-3476(05)81189-8.

Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.甲状腺功能亢进症抗甲状腺药物治疗后促甲状腺激素释放激素反应性与甲状腺抑制性的分离

J Clin Endocrinol Metab. 1976 Sep;43(3):543-9. doi: 10.1210/jcem-43-3-543.

Thyroid gland in Graves' disease: victim or culprit?格雷夫斯病中的甲状腺：受害者还是罪魁祸首？

Metabolism. 1970 Oct;19(10):760-72. doi: 10.1016/0026-0495(70)90074-0.

The long-acting thyroid stimulatory: is it of importance in Graves' disease.长效甲状腺刺激素：它在格雷夫斯病中重要吗？

N Z Med J. 1975 Jan 8;81(531):18-21.

Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.甲巯咪唑和丙硫氧嘧啶每日单次剂量治疗格雷夫斯甲亢的比较。

Clin Endocrinol (Oxf). 2004 Jun;60(6):676-81. doi: 10.1111/j.1365-2265.2004.02032.x.

Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.尽管长效甲状腺刺激素水平很高，但甲状腺功能仍具有可抑制性。

Ann Intern Med. 1972 Jan;76(1):77-84. doi: 10.7326/0003-4819-76-1-77.

引用本文的文献

Concentration-dependent regulation of thyrotropin receptor function by thyroid-stimulating antibody.促甲状腺素受体功能受甲状腺刺激抗体的浓度依赖性调节。

J Clin Invest. 2004 Jun;113(11):1589-95. doi: 10.1172/JCI21334.

Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey.放射性碘治疗格雷夫斯病数年之后促甲状腺素刺激抗体与促甲状腺素结合抑制性免疫球蛋白之间的关系：回顾性临床调查

J Endocrinol Invest. 1996 Nov;19(10):682-6. doi: 10.1007/BF03349039.

Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease.格雷夫斯病患者在服用甲巯咪唑治疗期间及治疗后的循环甲状腺自身抗体水平变化

J Endocrinol Invest. 1982 Jan-Feb;5(1):13-9. doi: 10.1007/BF03350476.

Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo.在体外和体内实验中，小鼠甲状腺激素的分泌对长效甲状腺刺激素（LATS）刺激的敏感性高于甲状腺环磷酸腺苷（cAMP）的积累。

J Endocrinol Invest. 1984 Feb;7(1):1-6. doi: 10.1007/BF03348367.

The thyrotrophin receptor.促甲状腺激素受体

Springer Semin Immunopathol. 1982;5(4):413-31. doi: 10.1007/BF01857428.

Clinical pharmacokinetics of antithyroid drugs.抗甲状腺药物的临床药代动力学

Clin Pharmacokinet. 1981 Nov-Dec;6(6):401-28. doi: 10.2165/00003088-198106060-00001.

An improved assay for thyrotropin-binding blocking activity in serum of patients with Graves' disease.

J Endocrinol Invest. 1984 Aug;7(4):335-9. doi: 10.1007/BF03351013.

Syndrome of persisting thyroid stimulating immunoglobulins and growth promotion of goiter combined with low thyroxine and high triiodothyronine serum levels in drug treated Graves' disease.药物治疗的格雷夫斯病中持续存在甲状腺刺激免疫球蛋白与甲状腺肿生长促进综合征合并血清甲状腺素水平降低和三碘甲状腺原氨酸水平升高

J Endocrinol Invest. 1983 Oct;6(5):389-94. doi: 10.1007/BF03347623.

TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.格雷夫斯病患者免疫球蛋白的促甲状腺激素替代活性与促甲状腺激素结合抑制活性

J Endocrinol Invest. 1983 Oct;6(5):375-8. doi: 10.1007/BF03347619.

The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.长期抗甲状腺治疗后，促甲状腺素结合抑制性免疫球蛋白（TBII）与甲状腺腺苷酸环化酶刺激抗体（TSAb）平行检测在格雷夫斯病中的预后价值。

J Endocrinol Invest. 1983 Aug;6(4):259-62. doi: 10.1007/BF03347586.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验